Regeneron Pharmaceuticals Inc (REGN):企業の財務・戦略的SWOT分析

◆英語タイトル:Regeneron Pharmaceuticals Inc (REGN) - Financial and Strategic SWOT Analysis Review
◆商品コード:SWOT20MY1130
◆発行会社(調査会社):GlobalData
◆発行日:2020年2月
◆ページ数:61
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥13,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥26,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥39,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Regeneron Pharmaceuticals Inc (REGN) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Regeneron Pharmaceuticals Inc (Regeneron) is a biopharmaceutical company, which discovers, develops, manufactures, and markets medicines for the treatment of serious medical conditions. Its marketed and pipeline products are focused on helping patients suffering with eye diseases, cancer, allergic and inflammatory diseases, metabolic and cardiovascular diseases, infectious diseases, neuromuscular diseases, and rare diseases. It develops products using its Trap and VelociSuite technology platforms, which include VelociGene, VelocImmune, VelociMouse, VelociMab, Veloci-Bi and other related technologies. The company operates manufacturing facilities in Rensselaer, New York and Limerick, Ireland. It also works in collaboration with strategic partners to develop, manufacture and commercialize its products. It sells its products to specialty pharmacies and distributors. The company and its subsidiaries operate in the US, Bermuda, the Netherlands, Ireland, Spain and the UK. Regeneron is headquartered in Tarrytown, New York, the US.

Regeneron Pharmaceuticals Inc Key Recent Developments

Feb 06,2020: Regeneron reports fourth quarter and full year 2019 financial and operating results
Feb 05,2020: Regeneron and HHS expand alliance to develop coronavirus drugs
Feb 04,2020: HHS, Regeneron collaborate to develop 2019-nCoV treatment
Jan 08,2020: Publication highlights Regeneron’s costimulatory bispecific antibodies, an emerging class of cancer immunotherapy
Dec 12,2019: Regeneron and Cold Spring Harbor Laboratory unveil new dedicated laboratories for student science education

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
Regeneron Pharmaceuticals Inc – Key Facts
Regeneron Pharmaceuticals Inc – Key Employees
Regeneron Pharmaceuticals Inc – Key Employee Biographies
Regeneron Pharmaceuticals Inc – Major Products and Services
Regeneron Pharmaceuticals Inc – History
Regeneron Pharmaceuticals Inc – Company Statement
Regeneron Pharmaceuticals Inc – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
Regeneron Pharmaceuticals Inc – Business Description
Product Category: Arcalyst
Overview
Performance
Product Category: Eylea
Overview
Performance
Product Category: Libtayo
Overview
Performance
Product Category: Other revenue
Performance
Product Category: Sanofi and Bayer collaboration revenue
Performance
R&D Overview
Regeneron Pharmaceuticals Inc – Corporate Strategy
Regeneron Pharmaceuticals Inc – SWOT Analysis
SWOT Analysis – Overview
Regeneron Pharmaceuticals Inc – Strengths
Regeneron Pharmaceuticals Inc – Weaknesses
Regeneron Pharmaceuticals Inc – Opportunities
Regeneron Pharmaceuticals Inc – Threats
Regeneron Pharmaceuticals Inc – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Regeneron Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Regeneron Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Type, 2014 to YTD 2020
Regeneron Pharmaceuticals Inc, Recent Deals Summary
Section 5 – Company’s Recent Developments
Feb 06, 2020: Regeneron reports fourth quarter and full year 2019 financial and operating results
Feb 05, 2020: Regeneron and HHS expand alliance to develop coronavirus drugs
Feb 04, 2020: HHS, Regeneron collaborate to develop 2019-nCoV treatment
Jan 08, 2020: Publication highlights Regeneron’s costimulatory bispecific antibodies, an emerging class of cancer immunotherapy
Dec 12, 2019: Regeneron and Cold Spring Harbor Laboratory unveil new dedicated laboratories for student science education
Dec 11, 2019: Sanofi and Regeneron to simplify antibody partnership
Nov 28, 2019: Congo trial shows investigational drugs reduce Ebola death risk
Nov 22, 2019: Regeneron’s Yancopoulos receives Columbia College’s Alexander Hamilton Award
Nov 07, 2019: Regeneron and Vyriad to develop oncolytic virus therapies
Nov 05, 2019: Regeneron reports third quarter 2019 financial and operating results
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
Regeneron Pharmaceuticals Inc, Key Facts
Regeneron Pharmaceuticals Inc, Key Employees
Regeneron Pharmaceuticals Inc, Key Employee Biographies
Regeneron Pharmaceuticals Inc, Major Products and Services
Regeneron Pharmaceuticals Inc, History
Regeneron Pharmaceuticals Inc, Other Locations
Regeneron Pharmaceuticals Inc, Subsidiaries
Regeneron Pharmaceuticals Inc, Key Competitors
Regeneron Pharmaceuticals Inc, Ratios based on current share price
Regeneron Pharmaceuticals Inc, Annual Ratios
Regeneron Pharmaceuticals Inc, Annual Ratios (Cont...1)
Regeneron Pharmaceuticals Inc, Annual Ratios (Cont...2)
Regeneron Pharmaceuticals Inc, Interim Ratios
Regeneron Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Regeneron Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Type, 2014 to YTD 2020
Regeneron Pharmaceuticals Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures
Regeneron Pharmaceuticals Inc, Performance Chart (2015 - 2019)
Regeneron Pharmaceuticals Inc, Ratio Charts
Regeneron Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Regeneron Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals by Type, 2014 to YTD 2020

★海外企業調査レポート[Regeneron Pharmaceuticals Inc (REGN):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • NORDSEE GmbH.:企業の戦略・SWOT・財務情報
    NORDSEE GmbH. - Strategy, SWOT and Corporate Finance Report Summary NORDSEE GmbH. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Eureka Forbes Limited:企業の戦略的SWOT分析
    Eureka Forbes Limited - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Diebold Nixdorf, Incorporated:戦略・SWOT・企業財務分析
    Diebold Nixdorf, Incorporated - Strategy, SWOT and Corporate Finance Report Summary Diebold Nixdorf, Incorporated - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Basware Oyj (BAS1V):企業の財務・戦略的SWOT分析
    Basware Oyj (BAS1V) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Cyient Ltd (CYIENT):企業の財務・戦略的SWOT分析
    Cyient Ltd (CYIENT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Dedeman Hotels & Resorts International:企業の戦略・SWOT・財務分析
    Dedeman Hotels & Resorts International - Strategy, SWOT and Corporate Finance Report Summary Dedeman Hotels & Resorts International - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT ana …
  • Petroleos Mexicanos:企業の戦略・SWOT・財務情報
    Petroleos Mexicanos - Strategy, SWOT and Corporate Finance Report Summary Petroleos Mexicanos - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Wood Group Mustang Inc:企業の戦略的SWOT分析
    Wood Group Mustang Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Quanta Computer Inc (2382):企業の財務・戦略的SWOT分析
    Quanta Computer Inc (2382) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Galen Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Galen Ltd (Galen), a subsidiary of Almac Group Ltd, is a pharmaceutical company. The company’s products include trustsaver, calceos, salivix, daunoxome, flotros, histofreezer, laxido, and saline steripoules, among others. It offers products in various therapy areas including angina, constipa …
  • Efore Oyj (EFO1V):企業の財務・戦略的SWOT分析
    Efore Oyj (EFO1V) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Intech Biopharm Ltd (6461):医療機器:M&Aディール及び事業提携情報
    Summary Intech Biopharm Ltd (Intech Biopharm) is a drug developing company that develops drugs for obstructive airway diseases. The company provides marketed products such as single ingredient generics such as Synvent, and Duasma, developed for asthma; and multi-ingredient generic, Synflutide, for a …
  • JSP Corp (7942):企業の財務・戦略的SWOT分析
    JSP Corp (7942) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • Almirall S.A.:企業の戦略・SWOT・財務分析
    Almirall S.A. - Strategy, SWOT and Corporate Finance Report Summary Almirall S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Oakdale Electric Cooperative:発電所・企業SWOT分析
    Oakdale Electric Cooperative – Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key …
  • STATS UK Ltd:企業の戦略的SWOT分析
    STATS UK Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Australian Leaders Fund Limited:企業の戦略・SWOT・財務情報
    Australian Leaders Fund Limited - Strategy, SWOT and Corporate Finance Report Summary Australian Leaders Fund Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Industrial Bank Of Korea:企業の戦略・SWOT・財務分析
    Industrial Bank Of Korea - Strategy, SWOT and Corporate Finance Report Summary Industrial Bank Of Korea - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • New York Life Insurance Company:企業のM&A・事業提携・投資動向
    New York Life Insurance Company - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's New York Life Insurance Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers …
  • Takara Holdings Inc (2531):企業の財務・戦略的SWOT分析
    Takara Holdings Inc (2531) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆